Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL398065 | 0.73 | — | — | |
| Water SCHEMBL396871 | 0.71 | TSHR (0.40) | TSHR | |
| Water SCHEMBL396872 | 0.71 | — | — | |
| SCHEMBL2157843 | 0.65 | — | — | |
| SCHEMBL11607084 | 0.65 | — | — | |
| SCHEMBL30483751 | 0.65 | — | — | |
| Glyoxylate SCHEMBL10712848 | 0.62 | — | — | |
| SCHEMBL609160 | 0.62 | LMNA (0.36) | TSHR | |
| SCHEMBL22801968 | 0.61 | CYP3A4 (0.32) | — | |
| SCHEMBL21628986 | 0.61 | ALDH1A1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11643425-B2 | Organometallic compounds for the manufacture of a semiconductor element or electronic memory | UMICORE AG & CO. KG (DE) | 2023-05-09 | — | — | US | disclosed |
| US-20210206790-A1 | ORGANOMETALLIC COMPOUNDS FOR THE MANUFACTURE OF A SEMICONDUCTOR ELEMENT OR ELECTRONIC MEMORY | UMICORE AG & CO, KG (DE) | 2021-07-08 | — | — | US | disclosed |
| EP-3599241-A1 | ORGANOMETALLIC COMPOUND | UMICORE AG & CO. KG (DE) | 2020-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11643425-B2 | Organometallic compounds for the manufacture of a semiconductor element or electronic memory | CRHR1, NR3C1, CRHR2 | TSHR 389/4885 |
| US-20210206790-A1 | ORGANOMETALLIC COMPOUNDS FOR THE MANUFACTURE OF A SEMICONDUCTOR ELEMENT OR ELECTRONIC MEMORY | CRHR1, NR3C1, CRHR2 | TSHR 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.